REDUCE MRSA was a collaborative effort. The study concept and design was created by investigators in the CDC’s Prevention Epicenter Program at the University of California, Irvine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Rush University and Washington University in St. Louis. AHRQ’s Healthcare Associated Infections program provided funding, and the research was conducted through AHRQ’s Developing Evidence to Inform Decisions about Effectiveness (DECIDE) network. The research was conducted across 43 HCA hospitals.
“This unprecedented partnership has yielded information that not only makes preventing MRSA and other antibiotic-resistant bacteria simpler and more effective, it sets a new standard for responsible infection prevention,” said Perlin.
All references to “Company” and “HCA” as used through this release refer to HCA Holdings, Inc. and its affiliates.